On Invalid Date, Cormedix (NASDAQ: CRMD) reported Q3 2023 earnings per share (EPS) of -$0.17, up 0% year over year. Total Cormedix earnings for the quarter were -$9.74 million. In the same quarter last year, Cormedix's earnings per share (EPS) was -$0.17.
As of Q4 2023, Cormedix's earnings has grown year over year. Cormedix's earnings in the past year totalled -$39.79 million.
What was CRMD's revenue last quarter?
On Invalid Date, Cormedix (NASDAQ: CRMD) reported Q3 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Cormedix's revenue was $6.82 thousand.
What was CRMD's revenue growth in the past year?
As of Q4 2023, Cormedix's revenue has grown -67.75% year over year. This is 172.69 percentage points lower than the US Biotechnology industry revenue growth rate of 104.93%. Cormedix's revenue in the past year totalled $29.70 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.